Publications
The following is a list of official publications from the ATMP Sweden consortium;
March 2023
”miRNome and Proteome Profiling of Human Keratinocytes and Adipose Derived Stem Cells Proposed miRNA-Mediated Regulations of Epidermal Growth Factor and Interleukin 1-Alpha.”link
July 2022
”A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective.” link
Sept 2021
”Xeno-free workflow exhibits comparable efficiency and quality of keratinocytes isolated from human skin biopsies” link
May 2021
”Acoustophoresis Enables the Label-Free Separation of Functionally Different Subsets of Cultured Bone Marrow Stromal Cells” link
September 2020
”Identification and Clinical Application of Immunological Receptors Targeting Mutated Antigens Expressed by Solid Tumors.” link
”Human serum albumin as a clinically accepted cell carrier solution for skin regenerative application” link
August 2020
”Statistic estimation of cell compressibility based on acoustophoretic separation data” link
”Bringing advanced therapies to the clinic: the Swedish National ATMP Consortium (CAMP/SWElife ATMP)” link
July 2020
”Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination” link
June 2020
”Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies.” link
”Acoustophoresis Enables the Label‐Free Separation of Functionally Different Subsets of Cultured Bone Marrow Stromal Cells” link
May 2020
”Karolinska Institutet Human Embryonic Stem Cell Bank.” link
March 2019
”HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice” link
December 2018
”A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia.” link
August 2018
”A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia.” link
April 2018
”Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML.” link
December 2017
”Gene therapy – from idea to reality” (Swedish) link
Related content
View recorded content from ATMP Sweden.
View conferences and events within the Swedish ATMP field.